# GLZHealth

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/glzhealth

- Industry: Healthcare IT
- Headquarters: Shenzhen, China
- Website: www.glzhealth.com
- Total disclosed funding: $10M
- Latest round: Series A (Jan 21, 2022)
- Investors on record: 4

## About

Established in 2017 and based in Shenzhen, China, GLZHealth is a medical platform that provides human papillomavirus vaccine appointment service. The company has completed 3 rounds of funding as of 2022. As of 2022, the company has worked with more than 1,000 medical institutions, serving more than 3 million people and more than 100 vaccination regions.

The company self-developed products include online vaccine booking service platform, medical testing service platform, assisted reproduction online service platform and digital operation platform for medical institutions. The online vaccine booking service platform provides flu vaccine, HPV vaccine, pneumonia vaccine, hepatitis B vaccine, chickenpox vaccine, tetanus vaccine, rabies vaccine and other appointment services. The medical testing service platform provides nucleic acid testing, HPV testing, health screening, HIV testing, genetic testing services.

## Funding rounds

- Series A, Jan 21, 2022 — IDG Capital, MPC, Next Capital
- Series A, Dec 28, 2021 — Sherpa Healthcare Partners
- Series A, Jan 15, 2021, $10M — IDG Capital, Next Capital

## Investors

- IDG Capital (https://capitalatlas.ai/funds/idg-capital) — Series A
- Next Capital — Series A
- Sherpa Healthcare Partners (https://capitalatlas.ai/funds/sherpa-healthcare-partners) — Series A
- MPC — Series A